The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF/ICSI

Human Reproduction

Volumn 19, Issue 8, 2004, Pages 1713-1718

  Mochtar, M H ^a,h   Bernardus, R E ^b   Hamilton, C J C M ^c   van Krevel, H ^c   Leerentveld, B ^d   van Kasteren, Y M ^e   Wiegerinck, M A H M ^f   Flierman, P ^g   Verhoeve, H V ^g   van der Veen, F ^h  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Gooi Noord Hospital   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

^d ISALA HOSPITAL   (Netherlands)

^e Location Alkmaar   (Netherlands)

^f MÁXIMA MEDICAL CENTER   (Netherlands)

^g ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Controlled ovarian stimulation; Flexible start; Follicle development; GnRH antagonist; ICSI; IVF

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GANIRELIX; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CELL COUNT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; INDIVIDUALIZATION; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OOCYTE; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

EID: 4344626344     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh334     Document Type: Article

References (21)

1. Albano C, Smitz J, Camus M, Rietmuller-Winzen H, Van Steirteghem A and Devroey P (1997) Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 67,917-922.
2. Al-Inany H and Alboulghar M (2002) Gonadotropin-releasing hormone antagonists for assisted conception. A Cochrane Review. Hum Reprod 17,874-885.
3. Caspi MD, Ron-El R, Golan A, Nachum H, Herman A, Soffer Y and Weinraub Z (1989) Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins. Fertil Steril 51,95-99.
4. Ditkoff EC, Cassidenti DL, Paulson RJ, Sauer MV, Wellington PL, Rivier J, Yen SSC and Lobo RA (1991) The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. Am J Obstet Gynecol 165,1811-1817.
5. Escudero E, Bosch E, Crespo J, Simon C, Remohi J and Pellicer A (2004) Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients. Fertil Steril 81,562-566.
6. European Middle East Orgalutran Study Group (2001) Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16,644-651.
7. European Orgalutran Study Group, Borm G and Mannaerts B (2000) Treatment with the gonadotropin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective safe and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod 15,1490-1498.
8. Fluker MR, Marshall LA, Monroe SE and Jaffe RB (1991) Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle. J Clin Endocrinol Metab 72,912-919.
9. Fraser HM (1990) Inhibitory effects of treatment with an LHRH antagonist on the ovulatory cycle are reduced when administered during the late follicular phase. Contraception 41,73-83.
10. Hall JE, Bhatta N, Adams JM, Rivier JE, Vale WW and Crowley Jr WF (1991) Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human. J Clin Endocrinol Metab 72,993-1000.
11. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P and Collins JA (1992) The routine use of gonadotropin-releasing hormone against prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 58,888-896.
12. Kolibianakis EM, Albano CA, Kahn J, Camus M, Tournaye H, Van Steirteghem AC and Devroey P (2003) Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril 79,873-880.
13. Kolibianakis EM, Albano CA, Camus M, Tournaye H, Van Steirteghem AC and Devroey P (2004) Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. J Clin Metab Endocrinol 88,5632-5637.
14. Ludwig M, Katalinic A, Banz C, Schroder AK, Loning M, Weiss JM and Diedrich K (2002) Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective randomized study. Hum Reprod 17,2842-2845.
15. Mais V, Kazer RR, Cetel NS, Rivier J, Vale W and Yen SSC (1986) The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe. J Clin Endocrinol Metab 26,1250-1255.
16. Marshall LA, Fluker MR, Jaffe RB and Monroe SE (1991) Inhibition of follicular development by a potent antagonist analog of gonadotropin-releasing hormone (Detrirelix). J Clin Endocrinol Metab 72,927-933.
17. Olivennes F, Fanchin R, Bouchard Ph, Taieb J, Selva J and Frydman R (1995) Scheduled administration of a gonadotrophid-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study. Hum Reprod 10,1382-1386.
18. Puissant F, Van Rysselberge M, Barlow P, Deweze J and Leroy F (1987) Embryo scoring as a prognostic tool in IVF treatment. Hum Reprod 2,705-708.
19. Ron-El R, Herman A, Golan A, Nachum H, Soffer Y and Caspi E (1991) Gonadotropins and combined gonadotropin-releasing hormone agonist-gonadotropins protocol in a randomized prospective study. Fertil Steril 55,574-578.
20. Vauthier D and Lefebre D (1989) The use of gonadotropin-releasing hormone analogs for in vitro fertilization: comparison between the standard form and long-acting formulation of D-Trp-6-luteinizing hormone-releasing hormone. Fertil Steril 51,100-104.
21. Veeck LL (1988) Oocyte assessment and biologic performance. Ann NY Acad Sci 541,259-274.